Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuro-immunology
What are your preferred treatments for relapsing remitting multiple sclerosis with comorbid IBD?
Related Questions
What is the role of inebilizumab in the maintenance treatment of IgG4-related disease?
How do you interpret conflicting findings on CSF immunoglobulin tests for work up of multiple sclerosis and its mimics?
In a patient with strong serologic evidence of SLE presenting with isolated bilateral lower limb sensorimotor neuropathy, normal neuroimaging, and CSF, would you initiate cyclophosphamide with pulse-dose steroids upfront, or reserve escalation (e.g., plasma exchange or immunosuppressants) for cases refractory to steroids?
Do you have any clinical experience regarding the administration of B cell depleting therapies in MS patients with splenectomy?
How does lack of success of rituximab treatment affect your decision to trial anti-CD19 therapies like inebilizumab?
When should patients be referred for advanced MRI testing to assess for CVS and PRL?
What is your approach to treatment when there is a multiple sclerosis reactivation while on natalizumab?
How do you decide when to discontinue immunotherapy for primary angiitis of the central nervous system (PACNS)?
When would you use ofatumumab for anti-NMDAR autoimmune encephalitis?
When should MOG-Ab be tested in patients with suspected autoimmune encephalitis with seizures and normal MRI?
